Trial intelligence / Profile preview

CBD for Pain Reduction After Ankle and Tibia Fracture Surgery

NCT04768478Phase 4Withdrawn

Sponsor
NYU Langone Health
Start
Oct 2021
Primary completion
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cannabidiol in postoperative pain, sponsored by NYU Langone Health. Planned start Oct 2021; status: withdrawn.

02

Drugs

cannabidiol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04768478.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04768478.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call